Additionally, we evaluated the PI3K/AKT/mTOR pathway, focusing on the AKT gene, which exhibited significant upregulation in high-grade gliomas compared to low-grade ones, suggesting increased tumor proliferation in the malignant stage. The gene discussed is MTOR; the disease is central nervous system cancer.